IgG4-associated pancreatitis – difficulties of diagnostics and treatment
https://doi.org/10.26295/OS.2021.11.17.007
Abstract
To date, IgG4-associated pancreatitis – type 1 autoimmune pancreatitis is a fairly rare disease of the pancreas, which causes great difficulties in the choice of therapeutic and diagnostic tactics for both surgeons and gastroenterologists. The disease is poorly understood and rarely discussed in routine clinical practice. Although, perhaps, in fact, the number of such patients is significantly greater. The prevailing etiological variant of the development of autoimmune pancreatitis remains the theory of lymphocyte activation under the influence of IgG4, which is normally one of the smallest immunoglobulins of class G, exhibiting both pro-inflammatory and anti-inflammatory activity. The inflammatory process caused by activated IgG4-positive leukocytes is characterized by the development of a diffuse or local process due to pronounced infiltration by lymphocytes and plasma cells, followed by their activation into fibroblasts and the formation of focal fibrosis. In the presented clinical case, we tried to describe all the difficulties faced by the patient, his family and friends, his attending physicians. A disease that developed over the years and led to a traumatic operation, the diagnosis – the setting of which required many years of diagnostic search, a treatment that allowed to save life and improve its quality, but due to delay, it turned out to be insufficient to fully rehabilitate the patient.
About the Authors
M. A. CherepninРоссия
Krasnoyarsk
E. V. Serova
Россия
Krasnoyarsk
S. I. Berdnikov
Россия
Krasnoyarsk
E. V. Chuprakov
Россия
Krasnoyarsk
Yu. B. Govorina
Россия
Krasnoyarsk
References
1. Mikulicz J. Ьber eine eigenartige symmetrishe Erkrankung der Trдnen und Mundspeicheldrьsen. Stuttgart: Beitr z Chir Fesrschr f Theodor Billroth, 1892. Рp. 610-630.
2. Kawaguchi K., Koike M., Tsuruta K. et al. Lymphoplasmacytic sclerosing pancreatitis with holangitis: a variant of primary sclerosing cholangitis extensively involving pancreas // Hum. Pathol. 1991; 22: 387-395.
3. Stone J. H., Khosroshahi A., Deshpande V. et al. Recommendations for the nomenclature of IgG4- related disease and its individual organ system manifestations // Arthr. Rheum. 2012; 64 (10): 3061-3067.
4. Okazaki K., Uchida K., Ikeura T., Takaoka M. Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system // J. Gastroenterol. 2013; 48 (3): 303-314.
5. Chari S. T., Kloppel G., Zhang L., et al. The autoimmune pancreatitis International cooperative study group (APICS). Histopathologic and clinical subtypes of autoimmune pancreatitis: The Honolulu consensus document // Pancreas. 2010; 39: 549-554.
6. Kim K. P., Kim M. U., Song M. H., et al. Autoimmune chronic pancreatitis // Am J Gastroenterol. 2004; 99: 1605-1616.
7. Nishimori I., Tomakoshi A., Olsuki M. J. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002 // Gastroenterology. 2007; 42 (18): 6-8.
8. Bordin D. S., Kucheryavyy Yu. A. Klyuchevyye pozitsii pan"yevropeyskikh klinicheskikh rekomendatsiy po diagnostike i lecheniyu khronicheskogo pankreatita v fokuse gastroenterologa [Key positions of panEuropean clinical guidelines for the diagnosis and treatment of chronic pancreatitis in the focus of a gastroenterologist] // RMJ. 2017; 10 (25): 1682-4024.
Review
For citations:
Cherepnin M.A., Serova E.V., Berdnikov S.I., Chuprakov E.V., Govorina Yu.B. IgG4-associated pancreatitis – difficulties of diagnostics and treatment. Lechaschi Vrach. 2021;(2):35-37. (In Russ.) https://doi.org/10.26295/OS.2021.11.17.007
JATS XML


















